Rima Izem

1.4k total citations
43 papers, 841 citations indexed

About

Rima Izem is a scholar working on Statistics and Probability, Economics and Econometrics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Rima Izem has authored 43 papers receiving a total of 841 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Statistics and Probability, 10 papers in Economics and Econometrics and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Rima Izem's work include Statistical Methods in Clinical Trials (11 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Advanced Causal Inference Techniques (6 papers). Rima Izem is often cited by papers focused on Statistical Methods in Clinical Trials (11 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Advanced Causal Inference Techniques (6 papers). Rima Izem collaborates with scholars based in United States, Switzerland and Malawi. Rima Izem's co-authors include Joel G. Kingsolver, David J. Graham, Mary Southworth, Marsha E. Reichman, Michael Wernecke, Jiemin Liao, Thomas MaCurdy, Yuqin Wei, Katrina Mott and Margie R. Goulding and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and The American Naturalist.

In The Last Decade

Rima Izem

40 papers receiving 827 citations

Peers

Rima Izem
Nathanael R. Fillmore United States
Abha Khandelwal United States
Keith P. Lewis United States
Mamata V. Kene United States
Gene Hart United States
Catherine Klein United States
Yael Lurie Israel
Rima Izem
Citations per year, relative to Rima Izem Rima Izem (= 1×) peers Christian Asseburg

Countries citing papers authored by Rima Izem

Since Specialization
Citations

This map shows the geographic impact of Rima Izem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rima Izem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rima Izem more than expected).

Fields of papers citing papers by Rima Izem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rima Izem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rima Izem. The network helps show where Rima Izem may publish in the future.

Co-authorship network of co-authors of Rima Izem

This figure shows the co-authorship network connecting the top 25 collaborators of Rima Izem. A scholar is included among the top collaborators of Rima Izem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rima Izem. Rima Izem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yimei, Robert M. Nelson, Rima Izem, et al.. (2024). Unlocking the Potential: A Systematic Review of Master Protocol in Pediatrics. Therapeutic Innovation & Regulatory Science. 58(4). 634–644.
2.
Izem, Rima, Emmanuel Zuber, Nadia Daizadeh, et al.. (2024). Decentralized Clinical Trials: Scientific Considerations Through the Lens of the Estimand Framework. Therapeutic Innovation & Regulatory Science. 58(3). 495–504. 7 indexed citations
3.
Cleary, Kevin, et al.. (2023). EasyTBSA as a method for calculating total body surface area burned: a validation study. Emergency Medicine Journal. 40(4). 279–284. 5 indexed citations
4.
Amgalan, Ariunzaya, Kushal Kapse, Rima Izem, et al.. (2022). Measuring intrauterine growth in healthy pregnancies using quantitative magnetic resonance imaging. Journal of Perinatology. 42(7). 860–865. 5 indexed citations
5.
Li, Yimei & Rima Izem. (2022). Novel clinical trial design and analytic methods to tackle challenges in therapeutic development in rare diseases. Annals of Translational Medicine. 10(18). 1034–1034. 11 indexed citations
6.
Izem, Rima, et al.. (2022). Real-World Data as External Controls: Practical Experience from Notable Marketing Applications of New Therapies. Therapeutic Innovation & Regulatory Science. 56(5). 704–716. 13 indexed citations
7.
Izem, Rima, et al.. (2021). Plasmodium falciparum clearance time in Malawian children with cerebral malaria: a retrospective cohort study. Malaria Journal. 20(1). 408–408. 4 indexed citations
8.
Chamberlain, James M., et al.. (2021). Evaluation of Communication and Safety Behaviors During Hospital-Wide Code Response Simulation. Simulation in Healthcare The Journal of the Society for Simulation in Healthcare. 17(1). e45–e50. 3 indexed citations
9.
Izem, Rima & Robert McCarter. (2021). Randomized and non-randomized designs for causal inference with longitudinal data in rare disorders. Orphanet Journal of Rare Diseases. 16(1). 491–491. 6 indexed citations
10.
Izem, Rima, et al.. (2021). Personal Protective Equipment Adherence of Pediatric Resuscitation Team Members During the COVID-19 Pandemic. Annals of Emergency Medicine. 78(5). 619–627. 5 indexed citations
11.
Nagamani, Sandesh C.S., Rima Izem, Deborah Schady, et al.. (2021). Biomarkers for liver disease in urea cycle disorders. Molecular Genetics and Metabolism. 133(2). 148–156. 8 indexed citations
12.
Zhang, Rongmei, Hui‐Lee Wong, Michael Wernecke, et al.. (2021). Trends in Erythropoiesis‐stimulating agent use and blood transfusions for chemotherapy‐induced anemia throughout FDA's risk evaluation and mitigation strategy lifecycle. Pharmacoepidemiology and Drug Safety. 30(5). 626–635. 1 indexed citations
13.
Gagne, Joshua J., Jennifer Popovic, Michael Nguyen, et al.. (2018). Evaluation of Switching Patterns in FDA’s Sentinel System: A New Tool to Assess Generic Drugs. Drug Safety. 41(12). 1313–1323. 11 indexed citations
14.
Ma, Haijun, et al.. (2018). Sources of Safety Data and Statistical Strategies for Design and Analysis: Transforming Data Into Evidence. Therapeutic Innovation & Regulatory Science. 52(2). 187–198. 5 indexed citations
15.
Izem, Rima, et al.. (2018). Sources of Safety Data and Statistical Strategies for Design and Analysis: Postmarket Surveillance. Therapeutic Innovation & Regulatory Science. 52(2). 159–169. 18 indexed citations
16.
Izem, Rima, et al.. (2015). The role of quantitative safety evaluation in regulatory decision making of drugs. Journal of Biopharmaceutical Statistics. 26(1). 17–29. 4 indexed citations
18.
Verme, Paolo & Rima Izem. (2008). Relative Deprivation with Imperfect Information. Economics bulletin. 4(7). 1–9. 6 indexed citations
19.
Knies, Jennifer L., et al.. (2006). The Genetic Basis of Thermal Reaction Norm Evolution in Lab and Natural Phage Populations. PLoS Biology. 4(7). e201–e201. 77 indexed citations
20.
Izem, Rima & Joel G. Kingsolver. (2005). Variation in Continuous Reaction Norms: Quantifying Directions of Biological Interest. The American Naturalist. 166(2). 277–289. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026